hiv-infections

Documents about hiv-infections

• Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection#125933ClinicalTrials.gov
• Exercise and Pioglitazone for HIV-Metabolic Syndromes#373722ClinicalTrials.gov
• A Study of LXR015-1 in HIV-Infected Patients#810596ClinicalTrials.gov
• Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study#853753ClinicalTrials.gov
• Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment#879047ClinicalTrials.gov
• A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease#884456ClinicalTrials.gov
• Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)#898226ClinicalTrials.gov
• Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV#907865ClinicalTrials.gov
• Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People#121462ClinicalTrials.gov
• Safety and Immune Response to a Clade C DNA HIV Vaccine#377278ClinicalTrials.gov
• Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine#459954ClinicalTrials.gov
• Comparison of Liquid Kaletra and Low Dose Kaletra Tablets#838530ClinicalTrials.gov
• Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT#842531ClinicalTrials.gov
• Prospective Cohort of HIV/HBV-coinfected Patients in Europe#844071ClinicalTrials.gov
• Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities#881318ClinicalTrials.gov
• Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)#885011ClinicalTrials.gov
• A Smartphone Application to Support Physical Activity in HIV Infected People#886953ClinicalTrials.gov
• Modulation of Immune Activation by Aspirin#892470ClinicalTrials.gov
• Papuan Indigenous Model of Male Circumcision#895925ClinicalTrials.gov
• Evaluation of Atazanavir Substitution Intervention (EASI) Study#902823ClinicalTrials.gov
• The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV#807666ClinicalTrials.gov
• Empowerment Intervention for Young Women - Phase I#829042ClinicalTrials.gov
• A Comparison of 141W94 and Indinavir in HIV-Infected Patients#805998ClinicalTrials.gov
• Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048#154702ClinicalTrials.gov
• A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers#311201ClinicalTrials.gov
• Outcomes of Anti-HIV Therapy During Early HIV Infection#826463ClinicalTrials.gov
• Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology#885318ClinicalTrials.gov
• Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine#136433ClinicalTrials.gov
• Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda#158062ClinicalTrials.gov
• Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults#256937ClinicalTrials.gov
• Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.#426647ClinicalTrials.gov
• Text Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected Women#802887ClinicalTrials.gov
• The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients#804761ClinicalTrials.gov
• Screen Smart: Using Digital Health to Improve HIV Screening and Prevention#810665ClinicalTrials.gov
• Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients#848092ClinicalTrials.gov
• Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019#849558ClinicalTrials.gov
• Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*#850147ClinicalTrials.gov
• A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication#858202ClinicalTrials.gov
• Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV#858552ClinicalTrials.gov
• Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants#893755ClinicalTrials.gov
• Raltegravir Intensification in HIV-infected Patients#906146ClinicalTrials.gov
• The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients#861195ClinicalTrials.gov
• Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)#18709ClinicalTrials.gov
• Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults#67927ClinicalTrials.gov
• A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV#226322ClinicalTrials.gov
• The Effect of Bacille Calmette Guerin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants#369870ClinicalTrials.gov
• Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)#804674ClinicalTrials.gov
• Development of a Tailored HIV Prevention Intervention for Young Men#807649ClinicalTrials.gov
• CASI-Plus mHealth for Ukraine's APS Program (Aim 2)#846408ClinicalTrials.gov
• Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen#849326ClinicalTrials.gov